Trial Profile
A retrospective observational study of eslicarbazepine acetate for the treatment of epilepsy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Dec 2015
Price :
$35
*
At a glance
- Drugs Eslicarbazepine acetate (Primary)
- Indications Epilepsy
- Focus Adverse reactions; Therapeutic Use
- 09 Dec 2015 New trial record